These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1373000)

  • 1. A supportive role of neural cell adhesion molecule (NCAM) in adhesion between leukaemic blasts and cytotoxic lymphocytes.
    Palucka AK; Porwit A; Reizenstein P
    Scand J Immunol; 1992 Apr; 35(4):399-406. PubMed ID: 1373000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conjugate formation by leukemic blasts from acute myeloid leukemia with cytotoxic lymphocytes.
    Palucka AK; Porwit A; Reizenstein P
    Leuk Lymphoma; 1993 Nov; 11(5-6):427-33. PubMed ID: 7907248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of leukemic blasts to lymphokine activated killer (LAK)-mediated cytotoxicity is not related to their adhesion properties.
    Palucka AK; Porwit A; Reizenstein P
    Eur J Haematol; 1991 Aug; 47(2):123-7. PubMed ID: 1716215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible mechanism of selective killing of myeloid leukemic blast cells by lymphokine-activated killer cells.
    Oblakowski P; Bello-Fernandez C; Reittie JE; Heslop HE; Galatowicz G; Veys P; Wilkes S; Prentice HG; Hazlehurst G; Hoffbrand AV
    Blood; 1991 May; 77(9):1996-2001. PubMed ID: 1708296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of leukaemic blasts to various subpopulations of lymphokine-activated killer cells.
    Palucka AK; Porwit A; Reizenstein P
    Scand J Immunol; 1993 Feb; 37(2):179-85. PubMed ID: 7679523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of acute myelogenous leukemia blasts to lysis by lymphokine-activated killer (LAK) cells and its clinical relevance.
    Archimbaud E; Thomas X; Campos L; Fiere D; Doré JF
    Leuk Res; 1992; 16(6-7):673-80. PubMed ID: 1378919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target lysis by human LAK cells is critically dependent upon target binding properties, but LFA-1, LFA-3 and ICAM-1 are not the major adhesion ligands on targets.
    Quillet-Mary A; Cavarec L; Kermarrec N; Marchiol-Fournigault C; Gil ML; Conjeaud H; Fradelizi D
    Int J Cancer; 1991 Feb; 47(3):473-9. PubMed ID: 1704356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion molecule-mediated signals regulate major histocompatibility complex-unrestricted and CD3/T cell receptor-triggered cytotoxicity.
    Galandrini R; Albi N; Zarcone D; Grossi CE; Velardi A
    Eur J Immunol; 1992 Aug; 22(8):2047-53. PubMed ID: 1379184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis.
    Savary CA; Lotzová E
    Lymphokine Cytokine Res; 1992 Jun; 11(3):149-56. PubMed ID: 1391234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of intercellular adhesion molecule 1 on small cell lung carcinoma cell lines by gamma-interferon enhances spontaneous and bispecific anti-CD3 x antitumor antibody-directed lymphokine activated killer cell cytotoxicity.
    Azuma A; Yagita H; Matsuda H; Okumura K; Niitani H
    Cancer Res; 1992 Sep; 52(18):4890-4. PubMed ID: 1381273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human interleukin 3 on the susceptibility of fresh leukemia cells to interleukin-2-induced lymphokine activated killing activity.
    Cesano A; Lista P; Bellone G; Geuna M; Brizzi MF; Rossi PR; Pegoraro L; Oberholtzer E; Matera L
    Leukemia; 1992 Jun; 6(6):567-73. PubMed ID: 1376379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-mediated cytotoxicity.
    Scheper RJ; Dalton WS; Grogan TM; Schlosser A; Bellamy WT; Taylor CW; Scuderi P; Spier C
    Int J Cancer; 1991 Jun; 48(4):562-7. PubMed ID: 1710609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells by upregulating target cell expression of ICAM-1.
    Bendall LJ; Kortlepel K; Gottlieb DJ
    Leukemia; 1995 Apr; 9(4):677-84. PubMed ID: 7723403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of adhesion molecules in lymphokine-activated killer cell killing of bladder cancer cells: further evidence for a third ligand for leucocyte function-associated antigen-1.
    Jackson AM; Alexandrov AB; Prescott S; James K; Chisholm GD
    Immunology; 1992 Jun; 76(2):286-91. PubMed ID: 1353063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias.
    Ikushima S; Yoshihara T; Matsumura T; Misawa S; Morioka Y; Hibi S; Imashuku S
    Int J Hematol; 1991 Oct; 54(5):395-403. PubMed ID: 1721853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells.
    Naganuma H; Kiessling R; Patarroyo M; Hansson M; Handgretinger R; Grönberg A
    Int J Cancer; 1991 Feb; 47(4):527-32. PubMed ID: 1671670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation.
    Zarcone D; Viale O; Cerruti G; Tenca C; Malorni W; Arancia G; Iosi F; Galandrini R; Velardi A; Moretta A
    Cell Immunol; 1992 Sep; 143(2):389-404. PubMed ID: 1380897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of acute leukemia cells to the cytotoxic activity of allogeneic and autologous lymphokine activated killer (LAK) effectors: correlation with the rate and duration of complete remission and with survival.
    Lauria F; Raspadori D; Rondelli D; Ventura MA; Foà R
    Leukemia; 1994 May; 8(5):724-8. PubMed ID: 8182932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-activated killer cytotoxicity against leukaemic blast cells.
    Tratkiewicz JA; Szer J; Boyd RL
    Clin Exp Immunol; 1990 Apr; 80(1):94-9. PubMed ID: 2323104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of adhesion molecules on acute leukemic blast cells and sensitivity to normal LAK activity.
    Raspadori D; Lauria F; Ventura MA; Rondelli D; Tura S
    Ann Hematol; 1993 Nov; 67(5):213-6. PubMed ID: 7694662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.